Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

K
Kümmel, Anne

IntiQuan AG
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Anne Kümmel
Favorite
Kabir, Abbas

BioAgilytix
(T0930-06-34) Assessing Parallelism of IFN-beta and IL-29 in Human K2EDTA Plasma Post Stimulation with LPS and PHA
Abbas Kabir
Favorite
Kaczynski, Edward J.

AbbVie Inc.
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Edward J. Kaczynski
Favorite
Kadajji, Veeran

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Veeran Kadajji
Favorite
Kadam, Ankur

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Ankur Kadam
Favorite
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Ankur Kadam
Favorite
Kadota, Kazunori

Wakayama Medical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Kazunori Kadota
Favorite
Kaffash, Ehsan

Virginia Commonwealth University
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Ehsan Kaffash
Favorite
Kafle, Prapti

Merck & Co., Inc.
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Prapti Kafle
Favorite
Kalari, Krishna

Mayo Clinic
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Krishna Kalari
Favorite
Kale, Parv

Waterford School
(M0930-10-55) Protective Effects of Angiotensin Receptor Blockers on Knee Joint Cartilage Volume: A Retrospective Analysis of Osteoarthritis Initiative Study
Parv Kale
Favorite
Kale, Vijay

Roseman University of Health Sciences
(M0930-10-55) Protective Effects of Angiotensin Receptor Blockers on Knee Joint Cartilage Volume: A Retrospective Analysis of Osteoarthritis Initiative Study
Vijay Kale
Favorite
Kalla, Chamundeswara Srinivasa Akash

University of Mississippi
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Chamundeswara Srinivasa Akash Kalla
Favorite
Kalra, Arjun

Fairleigh Dickinson University
(M1230-05-25) A Molecular Dynamics Study of the Impact of Water Content on Pre-nucleation Aggregates in Amorphous 2-Phenylamino Nicotinic Acid
Arjun Kalra
Favorite
Kalra, Priyata

Simulations Plus, Inc.
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Priyata Kalra
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Priyata Kalra
Favorite
Kamala, Poornima

IDBR
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Poornima Kamala
Favorite
Kamal, Nahid

US Food and Drug Administration
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Nahid Kamal
Favorite
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Nahid Kamal
Favorite
Kamath, Amrita

Genentech, Inc.
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Amrita Kamath
Favorite
(M1530-02-12) Characterizing Interactions of RO7297089, an Anti-B-Cell Maturation Antigen (BCMA)/CD16A Bispecific Tetravalent Antibody with Shed Soluble CD16A Antigen in Plasma In Vitro
Amrita Kamath
Favorite
Kamath, Satish

Bayer USA
(T1230-05-26) Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs
Satish Kamath
Favorite
Kamble, Shyam

University of Florida
(M1230-02-12) Metabolite Identification of a Kratom Alkaloid Speciogynine in Human Liver Microsomes and Hepatocytes
Shyam Kamble
Favorite
Kamel, Eman

University of Iowa
(W1130-11-61) Forced Degradation of Cell-Based Therapeutic Products Using Various Stresses and Use of Flow Imaging Microscopy for Identification of Damaged Cells and Cell Debris
Eman Kamel
Favorite
Kanabar, Pinal

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Pinal Kanabar
Favorite
Kanagala, Vijaya Sri

Malla Reddy College of Pharmacy
(W1230-03-15) Preparation of Lurasidone Hydrochloride Nanoparticles and Enhanced Bioavailability
Vijaya Sri Kanagala
Favorite
Kancharla, Vijayalakshmi

Mayo Clinic
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Vijayalakshmi Kancharla
Favorite
Kandagatla, Hari Priya

St. John's University
(M1030-01-06) Supersolubilization and Amorphization of a Weakly Acidic Drug, Flurbiprofen, by Applying Acid-Base Supersolubilization (ABS) Principle
Hari Priya Kandagatla
Favorite
(M1330-05-28) Application of Acid-Base Supersolubilization Principle to Telmisartan, a Weakly Acidic, High Melting, and Low Solubility Drug, to Lower Hot Melt Extrusion Temperature and Increase Drug Dissolution
Hari Priya Kandagatla
Favorite
(M1430-05-28) Development of 3D Printed Tablets of Weakly Acidic Drug-Flurbiprofen by Acid-Base Super-Solubilization at Lower Extrusion Temperature and Improved Printability
Hari Priya Kandagatla
Favorite
(T1030-05-29) Improving the Drug Release of Clofazimine by Developing Amorphous Solid Dispersions via Hot-Melt Extrusion Using the Acid-Base Supersolubilization Principle
Hari Priya Kandagatla
Favorite
(T1030-05-30) Moisture Sorption of Microcrystalline Cellulose
Hari Priya Kandagatla
Favorite
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Hari Priya Kandagatla
Favorite
Kandimalla, Karunya

University of Minnesota
(M1030-04-22) Amyloid Beta Peptides Inhibit Insulin Trafficking at the Blood-Brain-Barrier in Alzheimer's disease Brain
Karunya Kandimalla
Favorite
(M1430-07-37) Intracellular Trafficking of Cationic Bicelles and siRNA Cargo in an In Vitro BBB Model
Karunya Kandimalla
Favorite
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Karunya Kandimalla
Favorite
(T1530-06-35) Effect of Vasculotropic Dutch Amyloid Beta 40 on Blood-Brain Barrier (BBB) Endothelial Trafficking and Signaling
Karunya Kandimalla
Favorite
(W1030-07-38) Development of Targeted Nanovehicles to Deliver Biomolecules to Cerebrovascular Endothelium
Karunya Kandimalla
Favorite
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Karunya Kandimalla
Favorite
Kanehl, Melina

IMCD
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Melina Kanehl
Favorite
Kane, Maureen

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Maureen Kane
Favorite
Kane, Zoe

Quotient Sciences
(M1530-02-10) Predicting Belumosudil Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model
Zoe Kane
Favorite
Kanfer, Isadore

University of Toronto
(T1230-02-10) Revisiting Potency Classification of Topical Corticosteroids Using a Standardized Approach Involving Vasoconstrictor Assay (VCA)
Isadore Kanfer
Favorite
Kang, Il-Mo

Korea Institue of Geoscience and Mineral Resources
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Il-Mo Kang
Favorite
Kang, Ji-Hyun

Jeonbuk National University
(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers
Ji-Hyun Kang
Favorite
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
Ji-Hyun Kang
Favorite
Kang, Minseo

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Minseo Kang
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Minseo Kang
Favorite
Kang, Sangoh

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Sangoh Kang
Favorite
Kang, Xuejia

Auburn University
(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment
Xuejia Kang
Favorite
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Xuejia Kang
Favorite
(T1030-01-06) The Influence of Nanostructural Characteristics on Gene Transfection: Enhanced DNA Delivery Through Macropinocytosis and Efficient Dissociation by Large, Botryoid-Shaped Nanoparticles
Xuejia Kang
Favorite
(T1230-03-18) Targeting Brain Metastasis in Non-Small Cell Lung Cancer with EGFRT790M Mutation Using BBB-Penetrating Codelivery Liposomes
Xuejia Kang
Favorite
(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform
Xuejia Kang
Favorite
Kanna, Umakanth

BASF Corporation
(M1030-10-54) Use of Povidones and Copovidones as Solubility Enhancers for Itraconazole Using Hot Melt Extrusion
Umakanth Kanna
Favorite
(W0930-07-38) An Efficient Strategy to Overcome Poor Flow and Compressibility Issues of Lamivudine for a Robust Tablet Formulation Using a Coprocessed Excipient
Umakanth Kanna
Favorite
(W1030-03-15) The Evaluation of Methacrylic Acid Copolymer as a Direct Compressible Excipient for Erosion Based Sustained Release Matrix Tablets
Umakanth Kanna
Favorite
Kannheiser, Kristina

IMCD
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Kristina Kannheiser
Favorite
Kanumuri, Siva Rama Raju

University of Florida
(M1230-02-12) Metabolite Identification of a Kratom Alkaloid Speciogynine in Human Liver Microsomes and Hepatocytes
Siva Rama Raju Kanumuri
Favorite
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Siva Rama Raju Kanumuri
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Siva Rama Raju Kanumuri
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Siva Rama Raju Kanumuri
Favorite
Kanwal, Shahla

University of Bradford
(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension
Shahla Kanwal
Favorite
Kapadia, Chhanda

IMCD
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Chhanda Kapadia
Favorite
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Chhanda Kapadia
Favorite
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Chhanda Kapadia
Favorite
Kapre, Sumedha

Texas A&M University
(M1030-10-56) Development and Validation of Biorelevant Multimodal In Vitro Characterization Techniques for Assessing the Adhesiveness Performance of Transdermal Patches
Sumedha Kapre
Favorite
(T1530-03-18) Physicochemical Characterization and In Vitro/Ex Vivo Evaluation of Transdermal Gels of Baricitinib for Rheumatoid Arthritis
Sumedha Kapre
Favorite
Karagianni, Spyridoula

National and Kapodistrian University of Athens
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Spyridoula Karagianni
Favorite
Karamyan, Vardan

Oakland University
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Vardan Karamyan
Favorite
Karan, Kapish

Ashland Specialty Ingredients
(M0930-03-18) Evaluating the Versatility of Klucel™ Xtend HPC in Dual Active Allergy Relief Extended-Release Dosages
Kapish Karan
Favorite
(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
Kapish Karan
Favorite
(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
Kapish Karan
Favorite
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Kapish Karan
Favorite
Karim, Mazharul

University of Utah
(M1330-04-19) Stromal Fibrin Inhibition Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
Mazharul Karim
Favorite
Karkossa, Frank

University of Greifswald
(M1330-03-18) Can Individual Taste Perceptions Bias the Results of Taste Panel Studies? Lessons Learned from an In Vivo Investigation with Paediatric ODMTs
Frank Karkossa
Favorite
(T1330-03-18) Taking Medicines the Milky Way: How Does Milk Affect Disintegration of Mini-Tablets with a Taste-Masking Coating?
Frank Karkossa
Favorite
Karnik, Indrajeet

University of Mississippi
(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Indrajeet Karnik
Favorite
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Indrajeet Karnik
Favorite
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Indrajeet Karnik
Favorite
Karnik, Shane

Aliri USA, Inc.
(M1130-06-33) A Derivatization-Free LCMS Assay for 4β-Hydroxycholesterol
Shane Karnik
Favorite
(M1430-06-34) Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
Shane Karnik
Favorite
(W0930-06-34) Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma
Shane Karnik
Favorite
Karry, Krizia

BASF Corporation
(M1030-10-54) Use of Povidones and Copovidones as Solubility Enhancers for Itraconazole Using Hot Melt Extrusion
Krizia Karry
Favorite
(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients
Krizia Karry
Favorite
Karunanithi, Sheela

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Sheela Karunanithi
Favorite
Karve, Aniruddha

University of Cincinnati
(W0930-10-58) Translational Research to Facilitate Development of Novel Therapeutic Combination of Letrozole with a CDK 4/6 Inhibitor Ribociclib for the Treatment of Glioblastoma
Aniruddha Karve
Favorite
Karve, Tanvi

Mercer University
(M1030-03-16) Development and Characterization of PLGA Tip-Loaded Polymeric Microneedles for the Sustained, Week-Long Release of a Lipophilic Molecule-Carfilzomib
Tanvi Karve
Favorite
(M1230-01-04) Week-Long Transdermal Delivery of an Anxiolytic Drug Using Tip-Loaded PVA Microneedles
Tanvi Karve
Favorite
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Tanvi Karve
Favorite
(W1030-05-26) Transdermal Lamivudine Deep Eutectic Systems for the Long-Term Management of Pediatric Hepatitis B Virus and HIV Infections
Tanvi Karve
Favorite
Kashyap, Purna

Mayo Clinic
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Purna Kashyap
Favorite
Kassel, Lynn

Drake University
(T1230-11-65) Epinephrine Degradation in Pediatric Auto-Injectors
Lynn Kassel
Favorite
Kassim, Brittany

Merck & Co., Inc.
(T1130-10-54) Developing Robust Control Strategies for an Unexpected Fluorination Process Investigation
Brittany Kassim
Favorite
Kastantin, Mark

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Mark Kastantin
Favorite
Kastellorizios, Michail

University of North Texas Health Science Center
(M1130-05-26) Effect of Tumor Grade and Type on ECM-Liposome Interactions Measured by Contact Angle
Michail Kastellorizios
Favorite
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Michail Kastellorizios
Favorite
Kathawala, Mufaddal H

St. John's University
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Mufaddal H Kathawala
Favorite
Kathawala, Mufaddal H.

St. John's University
(T1030-05-29) Improving the Drug Release of Clofazimine by Developing Amorphous Solid Dispersions via Hot-Melt Extrusion Using the Acid-Base Supersolubilization Principle
Mufaddal H. Kathawala
Favorite
Kathiria, Lalji

Patheon, part of Thermo Fisher Scientific
(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Lalji Kathiria
Favorite
Katragadda, Usha

US Food and Drug Administration
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
Usha Katragadda
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Usha Katragadda
Favorite
Katsikis, Dimitris

National and Kapodistrian University of Athens
(W1130-03-15) A Biorelevant In Vitro Methodology for Assessing the Efficiency and Safety of Activated Charcoal in the Management of Drug-Induced Intestinal Dysbiosis
Dimitris Katsikis
Favorite
Katsumata, Toru

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Toru Katsumata
Favorite
Katz, Jonathan

National Institute on Drug Abuse
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Jonathan Katz
Favorite
Kaur, Manjinder

US Food and Drug Administration
(M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
Manjinder Kaur
Favorite
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Manjinder Kaur
Favorite
Kaushal, Gagan

Thomas Jefferson University
(M0930-07-41) Development and Evaluation of Buprenorphine Sublingual Formulation for the Treatment of Neonatal Opioid Withdrawal Syndrome
Gagan Kaushal
Favorite
Kawakami, Kohsaku

National Institute for Materials Science
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Kohsaku Kawakami
Favorite
(T1530-04-23) Constitution of a Helical Peptide on Exosome-Mimetic Vesicles
Kohsaku Kawakami
Favorite
Kawakita, Ryan

Gilead Sciences, Inc.
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
Ryan Kawakita
Favorite
Kawamoto, Ariumi

Tomita Pharmacaeutical Co., Ltd.
(M1030-10-57) A Solution that Improves the Poor Soluble API Dissolution by Using Porous Calcium Silicate FLORITE^®
Ariumi Kawamoto
Favorite
Kazi, Mohsin

King Saud University
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Mohsin Kazi
Favorite
(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Mohsin Kazi
Favorite
Keeton, Adam

Auburn University
(M0930-05-28) Disulfiram-Loaded Metal-Organic Nanoparticles Trigger Immunogenic Cell Death of the Triple-Negative Breast Cancer
Adam Keeton
Favorite
Keir, Raya

St. John's University
(W0930-01-06) Application of Acid-Base Supersolubilization (ABS) Principle to Increase Aqueous Solubility of Weakly Acidic Drug Indomethacin and Its Dissolution from ASD Prepared by Hot-Melt Extrusion
Raya Keir
Favorite
Kelchen, Megan

US Food and Drug Administration
(M1330-10-55) Evaluation of Critical Microstructural and Performance Attributes of Azelaic Acid Topical Gels
Megan Kelchen
Favorite
(T1030-09-48) Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories
Megan Kelchen
Favorite
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Megan Kelchen
Favorite
(W1130-01-02) Bioequivalence Approaches Utilized in Generic Drug Applications for Topical Drug Products Applied to the Skin
Megan Kelchen
Favorite
(W1130-10-56) Mechanistic Evaluation of Microstructure and Performance Attributes of Medicated Topical Shampoos
Megan Kelchen
Favorite
Kell, Sariah

23andMe Inc.
(W1030-06-33) Development of Sensitive Free and Total Assays for the Quantification of Soluble CD200R1 in Human Plasma Samples to Assess Drug-Target Engagement
Sariah Kell
Favorite
Kells, Siobhan

GlaxoSmithKline plc
(M1130-07-38) An Assessment of Factors Influencing the Integrity of Sprayed-On Silicone Oil Layer in Prefilled Syringes and Functionality of Prefilled Syringes
Siobhan Kells
Favorite
Kelwadkar, Ruchita

Rashtrasant Tukadoji Maharaj Nagpur University
(M1030-01-05) Novel Combination Approach to Enhance Solubility and Permeability of Pazopanib Using Phospholipid Complex and a Bioenhancer
Ruchita Kelwadkar
Favorite
Kemper, Benedict

Rottendorf Pharma GmbH
(M0930-11-65) Optimization of a Mini-Tablet Compression Process
Benedict Kemper
Favorite
Kenchappa, Ramesh

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Ramesh Kenchappa
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Ramesh Kenchappa
Favorite
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Ramesh Kenchappa
Favorite
Kendell, Isaac

University of Utah
(M1330-04-20) Immunomodulation Improves Cancer Cell Clearance During Multi-Antigen T Cell Hybridizer Therapy
Isaac Kendell
Favorite
KenKnight, Hattie

Seattle Children's Research Institute
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Hattie KenKnight
Favorite
Kent, Thomas

Texas A&M University
(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application
Thomas Kent
Favorite
Kenz, Zackary

Simulations Plus, Inc.
(W0930-10-57) Orforglipron Weight Loss and Nausea Accurately Simulated with OBESITYsym
Zackary Kenz
Favorite
Kerdsiri, Jeerakit

Naresuan University
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Jeerakit Kerdsiri
Favorite
Kerry, Michael

International Flavors and Frangrances
(W1130-10-55) Improving Sensitivity and Accuracy in Nitrite Measurement in Hydroxypropyl Methylcellulose
Michael Kerry
Favorite
Kesisoglou, Filippos

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Filippos Kesisoglou
Favorite
Keyhani, Anahita

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Anahita Keyhani
Favorite
Keys, Adelle

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Adelle Keys
Favorite
(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles
Adelle Keys
Favorite
Khairnar, Sakshi

University of Nebraska Medical Center
(M1430-07-39) Targeting Resistant Pathogens: The Promise of Vancomycin-Silver Nanoparticle Hybrids Against Vancomycin-Intermediate Staphylococcus Aureus (VISA)
Sakshi Khairnar
Favorite
Khajeh Pour, Sana

AbbVie Inc.
(M1030-02-07) Review of First-in-Human Trials for Gene Therapy in Ocular Diseases
Sana Khajeh Pour
Favorite
Khalil, Elie

University of Illinois Chicago
(W1030-01-06) Facile and Tunable Nanoparticle Delivery with Granular Hydrogels
Elie Khalil
Favorite
Khan, Aashna

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Aashna Khan
Favorite
Khanfar, Rami

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Rami Khanfar
Favorite
Khan, Jasim

University of Alabama at Birmingham
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Jasim Khan
Favorite
Khan, Mansoor

Texas A&M University
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Mansoor Khan
Favorite
(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application
Mansoor Khan
Favorite
(T1130-10-59) Quality Assessment of Four FDA-Approved Extended-Release Products of Divalproex
Mansoor Khan
Favorite
(T1330-05-26) Development and Characterization of Dose Flexible Printlets of Lamivudine Using Binder Jet – 3D Printing
Mansoor Khan
Favorite
Khanna, Pooja

Merck & Co., Inc.
(M1030-06-31) Utilizing LC-MS to Support of PABAD-Based Detection of Neutralizing Antibodies
Pooja Khanna
Favorite
Khare, Purva

Duquesne University
(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery
Purva Khare
Favorite
Khatun, Rahima

Duquesne University
(M1530-07-39) Compression-Induced Destabilization in Chlorpropamide-PVPVA Amorphous Solid Dispersions
Rahima Khatun
Favorite
(T1330-05-29) Selection of Excipients for Levodopa-Loaded Microparticles Prepared Using Spray-Drying
Rahima Khatun
Favorite
Khondoker, Alam

US Food and Drug Administration
(M1430-01-06) Formulation Effects of Marketed Oral Cavity Products on In Vitro Buccal Permeability
Alam Khondoker
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Alam Khondoker
Favorite
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Alam Khondoker
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Alam Khondoker
Favorite
Khurana, Nitish

University of Utah
(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening
Nitish Khurana
Favorite
(M1430-03-13) Combination eEF2K Gene and Drug Delivery for Treatment of Breast Cancer
Nitish Khurana
Favorite
(T0930-02-08) The Influence of Silica Nanoparticles with Varied Physicochemical Properties on the Immune Function of RAW 264.7 Macrophages
Nitish Khurana
Favorite
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Nitish Khurana
Favorite
Khuroo, Tahir Gani

Texas A&M University
(T1330-05-26) Development and Characterization of Dose Flexible Printlets of Lamivudine Using Binder Jet – 3D Printing
Tahir Gani Khuroo
Favorite
Kiang, San

Porton, J-Star
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
San Kiang
Favorite
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
San Kiang
Favorite
Kidd-Cartwright, Danica

Lonza
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Danica Kidd-Cartwright
Favorite
Kihara, Tsubasa

University of Shizuoka
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Tsubasa Kihara
Favorite
Kimball, Joseph

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Joseph Kimball
Favorite
Kim, Bo Mi

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Bo Mi Kim
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Bo Mi Kim
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Bo Mi Kim
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Bo Mi Kim
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Bo Mi Kim
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Bo Mi Kim
Favorite
kim, Chae-Jeong

Yonsei University
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Chae-Jeong kim
Favorite
Kim, Dong-Seon

Korea Institute of Oriental Medicine
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Dong-Seon Kim
Favorite
Kim, DongWon

Dankook University
(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability
DongWon Kim
Favorite
(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability
DongWon Kim
Favorite
(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability
DongWon Kim
Favorite
(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability
DongWon Kim
Favorite
Kim, Dong-Wook

Wonkwang University
(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers
Dong-Wook Kim
Favorite
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
Dong-Wook Kim
Favorite
Kim, Gwanyoung

Daewoong Pharmaceutical Co., Ltd.
(W0930-10-54) Comparative In Vitro Release and Clinical Pharmacokinetics of Leuprorelin Depot 3.75mg, a One-Month Sustained-Release Formulation of Leuprorelin Acetate
Gwanyoung Kim
Favorite
Kim, Haesun

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Haesun Kim
Favorite
Kim, Haley

Auburn University
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Haley Kim
Favorite
Kim, Haneul

Yonsei University
(M1230-10-57) Formulation of an Oil-in-Hydrogel Anti-Adhesion System for Sustained Release of Liposomes-Encapsulated 5-Fluorouracil
Haneul Kim
Favorite
(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy
Haneul Kim
Favorite
Kim, Hee Eun

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Hee Eun Kim
Favorite
Kim, Hee Joo

23andMe Inc.
(M0930-02-11) Toxicokinetics of 23ME-01473, a Novel Anti-ULBP6/2/5 Monoclonal Antibody, in Cynomolgus Monkeys Following Intravenous Bolus Injections in a 4-Week Toxicity Study
Hee Joo Kim
Favorite
(W1030-06-33) Development of Sensitive Free and Total Assays for the Quantification of Soluble CD200R1 in Human Plasma Samples to Assess Drug-Target Engagement
Hee Joo Kim
Favorite
Kim, Heeseo

Dankook University
(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability
Heeseo Kim
Favorite
(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability
Heeseo Kim
Favorite
(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability
Heeseo Kim
Favorite
(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability
Heeseo Kim
Favorite
Kim, Hye Soo

Yonsei University
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Hye Soo Kim
Favorite
Kim, Hyeonjeong

Yonsei University
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Hyeonjeong Kim
Favorite
Kim, Hyunjung

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Hyunjung Kim
Favorite
Kim, Jaehwan

Korea Institute of Geoscience and Mineral Resources
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Jaehwan Kim
Favorite
Kim, Jinho

Daewoong Pharmaceutical, Co., Ltd.
(W0930-10-54) Comparative In Vitro Release and Clinical Pharmacokinetics of Leuprorelin Depot 3.75mg, a One-Month Sustained-Release Formulation of Leuprorelin Acetate
Jinho Kim
Favorite
Kim, Jiwon

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Jiwon Kim
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Jiwon Kim
Favorite
Kim, Joonhee

Sungkyunkwan University
(M1530-06-33) Development of 3D-Printed Expandable Gastroretentive Drug Delivery System by Applying the Design of Experiment Approach
Joonhee Kim
Favorite
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Joonhee Kim
Favorite
Kim, Juhyun

US Food and Drug Administration
(M1430-02-11) Common Bioequivalence (BE) Deficiencies Identified in ANDAs Associated with Solid Oral Extended-Release Drugs in Various Therapeutic Areas: A Retrospective Survey of BE Study Data Submitted to the FDA
Juhyun Kim
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Juhyun Kim
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
Juhyun Kim
Favorite
Kim, Jung Suk

Hanyang University
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Jung Suk Kim
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Jung Suk Kim
Favorite
Kim, Junghyun

US Food and Drug Administration
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
Junghyun Kim
Favorite
Kim, Junsik

Daewoong Pharmaceutical Co., Ltd.
(W0930-10-54) Comparative In Vitro Release and Clinical Pharmacokinetics of Leuprorelin Depot 3.75mg, a One-Month Sustained-Release Formulation of Leuprorelin Acetate
Junsik Kim
Favorite
Kim, Keon

Sungkyunkwan University
(M1530-06-33) Development of 3D-Printed Expandable Gastroretentive Drug Delivery System by Applying the Design of Experiment Approach
Keon Kim
Favorite
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Keon Kim
Favorite
Kim, Keon-woong

Chungbuk National University
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
Keon-woong Kim
Favorite
Kim, Kilyoung

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Kilyoung Kim
Favorite
Kimmerling, KIrk

Fitebac
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
KIrk Kimmerling
Favorite
Kim, MinYoung

Chong Kun Dang Pharmaceutical Corp.
(T1130-07-39) Development of Novel Combination Therapy containing Lobeglitazone and Its Clinical Studies in Patients with Poorly Controlled Type 2 Diabetes
MinYoung Kim
Favorite
Kim, Myong-Jin

US Food and Drug Administration
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
Myong-Jin Kim
Favorite
(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
Myong-Jin Kim
Favorite
Kim, Na Yun

Il-Yang Pharm
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Na Yun Kim
Favorite
Kim, Nam Hyuck

Samyang Holdings Corporation
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Nam Hyuck Kim
Favorite
Kim, Sewon

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Sewon Kim
Favorite
Kim, Soohyun

Johns Hopkins University
(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue
Soohyun Kim
Favorite
Kim, Sung Rae

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Sung Rae Kim
Favorite
Kim, Taehyung

Chong Kun Dang Pharmaceutical Corp.
(T1130-07-39) Development of Novel Combination Therapy containing Lobeglitazone and Its Clinical Studies in Patients with Poorly Controlled Type 2 Diabetes
Taehyung Kim
Favorite
Kimura, Takayuki

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Takayuki Kimura
Favorite
Kim, Ye Ji

Yonsei University
(M1030-09-48) Polysaccharide Emulsion Gels for Reducing Postoperative Adhesions and Delivering 5-Fluorouracil
Ye Ji Kim
Favorite
Kim, Yulia

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Yulia Kim
Favorite
Kim, Yurah

Vantage Specialty Chemicals
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Yurah Kim
Favorite
Kinjo, Minori

US Food and Drug Administration
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
Minori Kinjo
Favorite
Kipping, Thomas

Merck KGaA
(M1030-01-04) Development of Extrusion-Based 3D Printed Hydrophilic Polymeric Transdermal Films of Pramipexole Dihydrochloride for Parkinson’s disease
Thomas Kipping
Favorite
(M1030-03-16) Development and Characterization of PLGA Tip-Loaded Polymeric Microneedles for the Sustained, Week-Long Release of a Lipophilic Molecule-Carfilzomib
Thomas Kipping
Favorite
(M1230-01-04) Week-Long Transdermal Delivery of an Anxiolytic Drug Using Tip-Loaded PVA Microneedles
Thomas Kipping
Favorite
(M1230-03-16) Enhanced Skin and Follicular Delivery of Tazarotene from PLGA Nanoparticles for the Treatment of Acne and Psoriasis
Thomas Kipping
Favorite
(M1430-01-05) Formulation and Skin Delivery of Quercetin Loaded PAMAM Dendrimer-Based Gel for Potential Anti-Inflammatory and Antioxidant Effect
Thomas Kipping
Favorite
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology
Thomas Kipping
Favorite
(W1230-01-05) Vacuum Compression Molding: A Novel Method to Fabricate Drug-Loaded Microneedles for Three-Day Transdermal Delivery of Palonosetron Hydrochloride
Thomas Kipping
Favorite
Klein, Sandra

University of Greifswald
(M1330-03-18) Can Individual Taste Perceptions Bias the Results of Taste Panel Studies? Lessons Learned from an In Vivo Investigation with Paediatric ODMTs
Sandra Klein
Favorite
(T1230-05-25) How are Medicines Administered to Pre-school Children? Current Status of a Global Survey on the Use of Dosing Vehicles
Sandra Klein
Favorite
(T1330-03-18) Taking Medicines the Milky Way: How Does Milk Affect Disintegration of Mini-Tablets with a Taste-Masking Coating?
Sandra Klein
Favorite
(W1030-05-30) One Like the Other? A Novel In Vitro Release Method to Ensure Proper Drug Release of Extended-Release Mini-Tablets for Paediatric Use
Sandra Klein
Favorite
Klimsa, Vojtech

University of Chemistry and Technology
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Vojtech Klimsa
Favorite
Klinken, Stefan

Heinrich Heine University Duesseldorf
(M1030-03-15) Formulation-Related Influences on the Ex Vivo Permeation of Lidocaine Hydrochloride Films
Stefan Klinken
Favorite
(M1230-11-63) Prediction Model for the Dry Film Thickness in the Continuous Manufacturing of Oral Films
Stefan Klinken
Favorite
Knappenburger, Terri

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Terri Knappenburger
Favorite
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Terri Knappenburger
Favorite
Knarr, Matthias

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
Matthias Knarr
Favorite
Knievel, Ryan

Thermo Fisher Scientific
(M1130-10-59) Prediction of Maximum Drug Loading in a Tablet Using Percolation Theory
Ryan Knievel
Favorite
K, Niharika

Malla Reddy College of Pharmacy
(W1230-03-15) Preparation of Lurasidone Hydrochloride Nanoparticles and Enhanced Bioavailability
Niharika K
Favorite
Knopp, Matthias

Bioneer A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Matthias Knopp
Favorite
(T1230-07-40) Evaluating the Gastric Integrity of Capsugel® Enprotect® Capsules in Fasted and Fed State Using the Dynamic Gastric Model (DGM)
Matthias Knopp
Favorite
Kobayashi, Hideo

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Hideo Kobayashi
Favorite
Kobyra, Julie

University of Pittsburgh
(M0930-05-29) Exploring the Effect of Manufacturing Methods in Long-Acting Injectable Formulation Characteristics
Julie Kobyra
Favorite
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Julie Kobyra
Favorite
Koch, Nathan

University of Liege
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Nathan Koch
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Nathan Koch
Favorite
Kodange, Niyati

University of Texas at Austin
(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
Niyati Kodange
Favorite
Kogan, Michael

Ashland Specialty Ingredients
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Michael Kogan
Favorite
Kohn, Bozena Michniak

Rutgers, The State University of New Jersey
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Bozena Michniak Kohn
Favorite
(T1430-01-06) Preparation and Characterization of Diclofenac Loaded Polymeric Nanoparticles from Mango Seed Kernel Starch
Bozena Michniak Kohn
Favorite
Kohnhorst, Casey

US Food and Drug Administration
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
Casey Kohnhorst
Favorite
Koka, Saisudha

Texas A&M University
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Saisudha Koka
Favorite
(T1130-04-22) Membrane Raft Redox Signalling Pathway Mediates Gut Microbial Metabolite TMAO-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction
Saisudha Koka
Favorite
Kolar, Jiři

University of Chemistry and Technology
(M1330-03-16) From Desired Dissolution Profile To Particle Size Distribution: Solving The Inverse Problem
Jiři Kolar
Favorite
Koleilat, Line

Purdue University
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Line Koleilat
Favorite
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Line Koleilat
Favorite
Koleti, Varun

Contract Pharmaceuticals Limited
(M1030-05-29) Preparation and Characterization of Pregabalin Loaded Liposomes for Topical Drug Delivery: Utilizing the Novel Platform Technology for the Effective Treatment of Neuropathic Pain Management
Varun Koleti
Favorite
Kolhe, Parag

Pfizer Inc.
(T1130-03-18) Leveraging Prior Knowledge for Drug Product Development: A Streamlined Lab-Scale Process Characterization Study Approach
Parag Kolhe
Favorite
Kolipauka, Ajay Reddy

University of Mississippi
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Ajay Reddy Kolipauka
Favorite
Kollala, Sai Sundeep

University of Nebraska Medical Center
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Sai Sundeep Kollala
Favorite
Kombian, Samuel

Kuwait University
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Samuel Kombian
Favorite
Komiyama, Natsuko

Chugai Research Institute for Medical Science Inc.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Natsuko Komiyama
Favorite
Kommineni, Nagavendra

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Nagavendra Kommineni
Favorite
Kompella, Uday B.

University of Colorado Denver
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Uday B. Kompella
Favorite
Konagurthu, Sanjay

Thermo Fisher Scientific
(M0930-10-56) Evaluating Food Effects in Oral Drug Delivery Using a Combination of PBPK Modeling and Molecular Dynamics Simulations
Sanjay Konagurthu
Favorite
(M1130-10-59) Prediction of Maximum Drug Loading in a Tablet Using Percolation Theory
Sanjay Konagurthu
Favorite
(T1530-11-64) A Rational Approach to Scaling-Up Lubrication in Pharmaceutical Tablet Manufacturing
Sanjay Konagurthu
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Sanjay Konagurthu
Favorite
Kondappan, Arasu

Thermo Fisher Scientific
(M1330-11-65) Compression Process Optimzation Using 2³ Full Factorial Design of Experiments
Arasu Kondappan
Favorite
Konfortova, Galia

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Galia Konfortova
Favorite
Kong, Sarah

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Sarah Kong
Favorite
Konishi, Koh

Tomita Pharmaceutical Co., Ltd.
(M1030-10-57) A Solution that Improves the Poor Soluble API Dissolution by Using Porous Calcium Silicate FLORITE^®
Koh Konishi
Favorite
Kono, Marina

Hoshi University
(W1030-09-52) Development of L-dopa-Loaded Nanofiber for Transbuccal Drug Delivery
Marina Kono
Favorite
Kontoudios, Niko

Seattle Children's Research Institute
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Niko Kontoudios
Favorite
Kopajtic, Theresa

National Institute on Drug Abuse
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Theresa Kopajtic
Favorite
Kopecek, Jindrich

University of Utah
(M1230-04-22) Novel Personalized Treatment for Multiple Myeloma: Multi-Antigen T Cell Hybridizers for T Cell Activation
Jindrich Kopecek
Favorite
(M1330-04-20) Immunomodulation Improves Cancer Cell Clearance During Multi-Antigen T Cell Hybridizer Therapy
Jindrich Kopecek
Favorite
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Jindrich Kopecek
Favorite
(T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
Jindrich Kopecek
Favorite
(T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
Jindrich Kopecek
Favorite
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Jindrich Kopecek
Favorite
(W1030-04-20) Combination of Multivalent DR5 Receptor Clustering Agonists and Histone Deacetylase Inhibitors for Treatment of Colon Cancer
Jindrich Kopecek
Favorite
Korang-Yeboah, Maxwell

US Food and Drug Administration
(M1530-11-60) Impact of X-Ray Micro-CT Resolution on Quantification of Quality Attributes and Simulated Mass Transport Properties of Lyophilized Products
Maxwell Korang-Yeboah
Favorite
Kordorwu, Victus

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Victus Kordorwu
Favorite
Kossor, Christopher

New Jersey Institute of Technology
(M1430-11-65) Particle Engineering Approach to Formulating Hot Melt Extrusion Amorphous Solid Dispersion Tablets
Christopher Kossor
Favorite
(T1030-11-64) Mechanistic Prediction of Tablet Breaking Force for Binary Blends Based on Individual Component Properties
Christopher Kossor
Favorite
Kostaridis, Alexandros

National and Kapodistrian University of Athens
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Alexandros Kostaridis
Favorite
Kosuri, Shashank

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Shashank Kosuri
Favorite
Kota, Sri Sai Nikitha

Creighton University
(T0930-05-29) Pulmonary Delivery of mRNA via Engineered Chitosan Nanoparticles: Development and Application
Sri Sai Nikitha Kota
Favorite
Kothandapani, Anbarasi

PPD Laboratories
(M1330-11-60) The Effects of Interfering Viral Particles on the Probability of Detecting Replication-Competent Adeno-Associated Virus (rcAAV) in a Replication-Based Cell Assay
Anbarasi Kothandapani
Favorite
Kothapalli, Sri-Rajasekhar

Pennsylvania State University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Sri-Rajasekhar Kothapalli
Favorite
Kothari, Khyati

Merck & Co., Inc.
(W0930-10-59) Matrix Comparability Assessment between 3.2% Sodium Citrate and 3.8% Sodium Citrate Human Plasma in PK and ADA Assays
Khyati Kothari
Favorite
Kousba, Ahmed

Bioagilytix San Diego
(M0930-02-11) Toxicokinetics of 23ME-01473, a Novel Anti-ULBP6/2/5 Monoclonal Antibody, in Cynomolgus Monkeys Following Intravenous Bolus Injections in a 4-Week Toxicity Study
Ahmed Kousba
Favorite
(M1130-02-11) Toxicokinetics of cNP8, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Ahmed Kousba
Favorite
(M1330-02-11) Toxicokinetics of cP12, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Ahmed Kousba
Favorite
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
Ahmed Kousba
Favorite
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Ahmed Kousba
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
Ahmed Kousba
Favorite
Kovacs, Erika

Abzena
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Erika Kovacs
Favorite
Krüse, Jacob
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
Jacob Krüse
Favorite
Kraft, Walter

Thomas Jefferson University
(M0930-07-41) Development and Evaluation of Buprenorphine Sublingual Formulation for the Treatment of Neonatal Opioid Withdrawal Syndrome
Walter Kraft
Favorite
Kramer, William

Kramer Consulting, LLC
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
William Kramer
Favorite
Krull, Brett

Arrowhead Pharmaceuticals, Inc.
(M1030-06-35) Development and Optimization of a Highly Sensitive and Selective Anion Exchange Liquid Chromatography with Fluorescence Detection Assay for Quantitation of siRNA Oligonucleotide Therapeutic Compounds
Brett Krull
Favorite
Krull, Scott

US Food and Drug Administration
(T1430-11-61) Predictive Residence Time Distribution Models for Continuous Powder Blending
Scott Krull
Favorite
(T1530-11-60) Evaluation of Near Infrared (NIR) for the Quantitation of Low Dose Drugs
Scott Krull
Favorite
Kshirsagar, Sharvari

Mercer University
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Sharvari Kshirsagar
Favorite
(M1230-03-16) Enhanced Skin and Follicular Delivery of Tazarotene from PLGA Nanoparticles for the Treatment of Acne and Psoriasis
Sharvari Kshirsagar
Favorite
(T1130-06-34) In Vitro Topical and Transdermal Delivery of 4-Phenylbutyric Acid Emulsome Loaded Foam Formulation for the Treatment of Chemical Warfare Agent-Induced Skin Injury
Sharvari Kshirsagar
Favorite
(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Sharvari Kshirsagar
Favorite
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Sharvari Kshirsagar
Favorite
(W1230-01-05) Vacuum Compression Molding: A Novel Method to Fabricate Drug-Loaded Microneedles for Three-Day Transdermal Delivery of Palonosetron Hydrochloride
Sharvari Kshirsagar
Favorite
Kubal, Bhakti

IMCD
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Bhakti Kubal
Favorite
Kubova, Hana

Academy of Sciences of the Czech Republic
(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone
Hana Kubova
Favorite
Kudo, Takayuki

Meiji Pharmaceutical University
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Takayuki Kudo
Favorite
Kudova, Eva

Academy of Sciences of the Czech Republic
(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone
Eva Kudova
Favorite
Kuebler, Sigrid

Yokogawa Fluid Imaging Technologies
(T1330-11-60) Flow Imaging Microscopy for Monitoring Subvisible and Submicron Particles in Cell and Gene Therapies
Sigrid Kuebler
Favorite
Kuentz, Martin

University of Applied Sciences and Arts Northwestern Switzerland
(M1130-07-41) Photonic Formulations of Hydroxypropyl Cellulose – Study of Mixtures with a Pharmaceutical Potential
Martin Kuentz
Favorite
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Martin Kuentz
Favorite
Kulkarni, Nishant

Regeneron Pharmaceuticals
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Nishant Kulkarni
Favorite
Kulkarni, Pushkar

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Pushkar Kulkarni
Favorite
Kulkarni, Sameer

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Sameer Kulkarni
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Sameer Kulkarni
Favorite
Kumar, Balawant

University of Nebraska Medical Center
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Balawant Kumar
Favorite
Kumari, Neha

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Neha Kumari
Favorite
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Neha Kumari
Favorite
Kumari, Shikha

University of Nebraska Medical Center
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Shikha Kumari
Favorite
Kumar, Narender

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Narender Kumar
Favorite
Kumar, Ravi

University of Alabama
(M1330-01-04) The Non-GLP Dose Range-Finding Study on Lymphatic-Targeting of Cyclosporine in Mrl-lpr Mouse Model of SLE
Ravi Kumar
Favorite
(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury
Ravi Kumar
Favorite
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Ravi Kumar
Favorite
(T1530-04-19) Lymphatic Targeting of Cyclosporine Improves Survival and Ameliorates Lupus-Like Autoimmune Disease in NZB/W Mice
Ravi Kumar
Favorite
Kummel, Andrew

University of California San Diego
(M1130-10-54) Advancing Treatment for Metastatic Triple Negative Breast Cancer: Liposomal Oncolytic Adenovirus as a Novel Neoadjuvant Therapy
Andrew Kummel
Favorite
Kunamneni, Adinarayana

Mayo Clinic
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Adinarayana Kunamneni
Favorite
Kunda, Nitesh

St. John's University
(T0930-07-41) Pulmonary Delivery of Trametinib-Encapsulated Nanostructured Lipid Carriers for Non-Small Cell Lung Cancer
Nitesh Kunda
Favorite
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Nitesh Kunda
Favorite
(W1130-09-49) Tyrosine Kinase Inhibitor Loaded Inhalable Liposomal Formulation for Non-Small Cell Lung Cancer
Nitesh Kunda
Favorite
Kunta, Jeevan

Corcept Therapeutics
(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
Jeevan Kunta
Favorite
Kuntz, Michelle

University of Florida
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Michelle Kuntz
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Michelle Kuntz
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Michelle Kuntz
Favorite
Kuo, Hsiaohsuan

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Hsiaohsuan Kuo
Favorite
Kuo, Lawrence

Mebias Discovery, Inc.
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Lawrence Kuo
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
Lawrence Kuo
Favorite
Kusakabe, Yuna

Tokyo Medical and Dental University
(T1030-04-24) Oren-gedoku-to, a Traditional Chinese Medicine, Prevents the Hyperglycemia Caused by Chronic Olanzapine Administration via Hypothalamic AMP-Activated Protein Kinase Activity
Yuna Kusakabe
Favorite
Kutsche, Spencer

Alcami Corporation
(T1130-10-58) Effective Product Life-Cycle Management Through Continued Process Verification (Stage 3) Using Statistical Software
Spencer Kutsche
Favorite
Kwarteng, Priscilla

PATH
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Priscilla Kwarteng
Favorite
kwon, ji-hyeon

Chungbuk National University
(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers
ji-hyeon kwon
Favorite
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
ji-hyeon kwon
Favorite
Kyomuhangi, Annet

University of Kentucky
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Annet Kyomuhangi
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Annet Kyomuhangi
Favorite